Skip to main content
Penumbra Inc logo

Penumbra Inc — Investor Relations & Filings

Ticker · PEN ISIN · US70975L1070 LEI · 549300RGE06P3ECANU72 US Manufacturing
Open in API
Filings indexed 922 across all filing types
Latest filing 2016-08-09 Interim / Quarterly Rep…
Country US United States of America
Listing US PEN

About Penumbra Inc

https://www.penumbrainc.com/

Penumbra Inc. is a global healthcare company that designs, develops, manufactures, and markets innovative medical devices. The company specializes in interventional therapies for challenging medical conditions within the neurovascular and peripheral vascular markets. Its product portfolio addresses conditions such as acute ischemic stroke, hemorrhagic stroke, and vascular aneurysms. Key technologies include aspiration systems for the revascularization of patients with acute ischemic stroke (e.g., the PENUMBRA SYSTEM) and embolization coil systems for vessel occlusion (e.g., the Swift Coil System). The company focuses on creating novel technologies to improve patient outcomes.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q2 2016
2016-08-09 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated August 9, 2016. It announces the financial results for the second fiscal quarter ended June 30, 2016, and includes a press release as an exhibit. The text explicitly states that the press release is furnished as an exhibit and incorporated by reference, and the document itself is short (2927 characters). There are no actual financial statements or detailed financial data within this text, only a summary and reference to the press release. According to the 'Menu vs Meal' rule, this is an announcement of financial results rather than the full earnings release itself. Therefore, the document should be classified as a Regulatory Filing (RNS), which is the fallback for such announcements and filings that do not contain substantive financial data themselves.
2016-08-09 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated June 8, 2016, reporting the submission of matters to a vote of security holders at the Annual Meeting of Stockholders. It details the voting results on director elections, ratification of the independent auditor, and ratification of equity incentive plan terms. The content focuses on official voting results from the shareholder meeting, not the meeting materials or the meeting itself. The document length is 3809 characters, which is relatively short and consistent with a voting results announcement rather than a full report or presentation. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2016-06-08 English
FORM 4
Director's Dealing
2016-05-23 English
FORM 4
Director's Dealing
2016-05-23 English
FORM 4
Director's Dealing
2016-05-23 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.